Article info
PDFDiagnostics
Short report
Leveraging the power of new molecular technologies in the clinical setting requires unprecedented awareness of limitations and drawbacks: experience of one diagnostic laboratory
- Correspondence to Dr Landry Nfonsam, Department of Genetics, Children’s Hospital of Eastern Ontario, Ottawa, K1H8L1, Ontario, Canada; LNfonsam{at}cheo.on.ca
Citation
Leveraging the power of new molecular technologies in the clinical setting requires unprecedented awareness of limitations and drawbacks: experience of one diagnostic laboratory
Publication history
- Received April 24, 2018
- Revised August 13, 2018
- Accepted August 27, 2018
- First published September 21, 2018.
Online issue publication
May 28, 2019
Article Versions
- Previous version (28 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.